All news from Anaesthesiology

Combination therapy to treat PCOS and Severe Hirsutism

Combining an estrogen-progesterone oral contraceptive pill (OCP) with the anti-androgen bicalutamide is more effective than an OC alone in treating severe hirsutism in women with polycystic ovary syndrome (PCOS), according to a double-blind randomized controlled trial from Italy.

A Novel Therapy to Prevent Dangerous Results of Snakebites

A University of Arizona researcher developing a therapy to prevent or delay the dangerous results of rattlesnake and other venomous snakebites in humans has shown that a combination of carbon monoxide and iron inhibits snake venom's effects for up to an hour in animals, a major advance in bringing the treatment to market.

Microbeads allows a Safer Route to Ultrasonic Therapy

Researchers at Duke University have discovered a way to enhance the effectiveness and safety of sonogenetics or ultrasonic modulation , emerging techniques that use sound waves to control the behavior of individual neurons or to promote tissue growth and wound healing in other cells.

Impact of Physician Networks on Medicare Beneficiaries

In the social network analysis of Medicare data, researchers reported that total spending was higher for patients of physicians with more connections to other physicians and more shared care outside of their network. Patients whose physicians’ networks had more primary care physicians had more primary care visits and fewer specialist and emergency visits.

Revefenacin: A new drug therapy for COPD

Management of chronic obstructive pulmonary disease (COPD) is treated principally by bronchodilators and drugs that reduce the frequency and severity of acute exacerbations. We have no agents that have been shown to prolong life other than extended oxygen therapy in those COPD patients who have long-term hypoxemiaRevefenacin is a new long-acting anticholinergic agent. A study recently published in Respiratory Research demonstrates its safety and efficacy. 

Palliative Care Curbs Psychological Distress in HSCT Patients

Palliative care at the time of hematopoietic stem cell transplant (HSCT) can reduce the psychological distress caused by the transplant interventions, a new study published in the Journal of Clinical Oncology. The study found that patients who received palliative care while hospitalized for HSCT experienced a "remarkable and sustained improvement" in depression and posttraumatic stress disorder (PTSD) symptoms 6 months following their transplant.